Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids

Guoqiang Sun1, Flavia Chiuppesi2, Xianwei Chen1

  • 1Division of Stem Cell Biology Research, Department of Developmental and Stem Cell Biology, Beckman Research Institute of City of Hope, 1500 E. Duarte Road, Duarte, CA 91010, USA.

Cell Reports. Medicine
|November 18, 2020
PubMed

Insights

Human cytomegalovirus (HCMV) infection impairs brain development in organoids, causing growth reduction and abnormal neural activity. Neutralizing antibodies targeting the HCMV pentamer complex can prevent these defects.

Area of Science:

  • Neuroscience
  • Virology
  • Developmental Biology

Background:

  • Congenital human cytomegalovirus (HCMV) infection is a primary cause of neurodevelopmental deficits.
  • The mechanisms of HCMV neuropathogenesis are not fully understood.
  • Species specificity of HCMV hinders direct study in animal models.

Purpose of the Study:

  • To investigate the effects of HCMV on human brain development using a novel in vitro model.
  • To explore the potential of neutralizing antibodies (NAbs) in mitigating HCMV-induced brain abnormalities.

Main Methods:

  • Utilized human-induced pluripotent stem cell-derived brain organoids.
  • Infected organoids with a clinical-like HCMV strain.
  • Assessed organoid growth, cortical layer formation, and neural network activity.
  • Evaluated the efficacy of NAbs targeting the HCMV pentamer complex.

Main Results:

  • HCMV infection led to reduced brain organoid growth and impaired cortical layer development.
  • Abnormal calcium signaling and neural network activity were observed in infected organoids.
  • NAbs targeting the HCMV pentamer complex successfully prevented HCMV-induced developmental deficits.

Conclusions:

  • HCMV can directly impair human brain development and function in a three-dimensional cellular system.
  • Neutralizing antibodies offer a potential therapeutic strategy to mitigate HCMV-related brain defects.

Related Concept Videos